CELEX: 62018TN0502
Language: en
Date: 2018-08-22 00:00:00
Title: Case T-502/18: Action brought on 22 August 2018 — Pharmadom v EUIPO — IRF (MediWell)

15.10.2018   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 373/15
            
         
      Action brought on 22 August 2018 — Pharmadom v EUIPO — IRF (MediWell)
      (Case T-502/18)
      (2018/C 373/17)
      Language of the case: English
      
         Parties
      
      
         Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M-P. Dauquaire, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: IRF s. r. o. (Bratislava, Slovakia).
      
         Details of the proceedings before EUIPO
      
      
         Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal
      
         Trade mark at issue: Application for European Union figurative mark MediWell — Application for registration No 15 078 645
      
         Procedure before EUIPO: Opposition proceedings
      
         Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 8 June 2018 in Case R 6/2018-5.
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision;
               
            
                  —
               
               
                  annul the decision of the Opposition Division;
               
            
                  —
               
               
                  refuse the mark applied for;
               
            
                  —
               
               
                  order EUIPO to pay the costs.
               
            
         Plea in law
      
      
                  —
               
               
                  Infringement of Art. 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.